Synergistic effects of ISL1 and KDM6B on non-alcoholic fatty liver disease through the regulation of SNAI1.

Fei ZhaoJinjing KeWensheng PanHanghai PanChuanyong Guo

Published in: Molecular medicine (Cambridge, Mass.) (2022)

Taken together, these findings highlighted that ISL1 effectively ameliorated NAFLD by inducing the expressions of KDM6B and SNAI1, which might be a promising drug for the treatment of NAFLD.

Keyphrases

emergency department
cancer therapy
drug delivery
replacement therapy
electronic health record